Human cellular model for investigating cortico-striatal-midbrain neural pathways

Inventors

Pasca, Sergiu P. • Miura, Yuki

Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Assignees

Leland Stanford Junior University

Stanford University

Todd Coleman is an associate professor of bioengineering at Stanford University. His research combines applied probability, physiology, and bioelectronics to develop methods and devices for monitoring and modulating nervous-system and other physiological activity, including brain and visceral-organ signals.

Publication Number

US-12767927-B2

Patent

Publication Date

2026-10-20

Expiration Date


Abstract

Human striatal and midbrain organoids or spheroids are generated in vitro, which may be generated at least in part from human pluripotent stem (hPS) cells. Such spheroids model the regions of the human brain and comprise specific sets of cells that are associated with the striatum, including mature medium spiny neurons, and midbrain of a human, and that can be subsequently assembled with the cortex to form cortico-striatal-midbrain circuits in vitro.

Core Innovation

The invention describes a midbrain-striatal assembloid formed from human pluripotent stem cell-derived midbrain and striatal spheroids. The spheroids are cultured in direct contact, and the resulting assembloid comprises human midbrain neurons projecting from the midbrain spheroid into the striatal spheroid. The described model brings these neural populations together in a human in vitro system.

The background section is not included in the provided partial content, so the problem being solved is not explicitly described in patent. The partial content proposes the midbrain-striatal assembloid for studying neural-circuit development and disease and for screening candidate treatments. It also reports characterization of midbrain dopaminergic cell populations and projection formation into the striatal spheroid.

Claims Coverage

The provided claims identify one independent claim. It covers producing a midbrain-striatal assembloid from separately generated midbrain and striatal spheroids and bringing them into direct contact to form projections between the spheroids.

Midbrain-striatal assembloid formation

The method produces human midbrain and striatal spheroids from human pluripotent stem cells and cultures the spheroids in direct contact, such that human midbrain neurons project from the midbrain spheroid into the striatal spheroid.

The independent claim covers the formation of a human midbrain-striatal assembloid with midbrain neuron projections into a striatal spheroid.

Stated Advantages

Not explicitly described in patent.

Documented Applications

Studying neural-circuit development and disease.

Screening candidate treatments.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.